Sign in to view content

Should We Ever Consider Stopping Treatment for Neovascular AMD?

Rahul N. Khurana, MD, FASRS

Video
Published 2020

Related

One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO
Mark R. Barakat, MD
Updates from the Field
2020
Episode 32 - Change in Management after Vitreous Culture in Endophthalmitis after Intravitreal Injections-Dr. James Vander
Keyvan Koushan, MD, FRCSC
Member Podcasts
2020
The Average Patient Does Not Enter Your Office: What Can We Learn About Treating nAMD From Individual Patient Responses
David S. Boyer, MD
Annual Meeting Talks
2019

Category: Age-Related Macular Degeneration

See more